Last reviewed · How we verify
Placebo of Baloxavir Marboxil tablets — Competitive Intelligence Brief
phase 3
Virology/Influenza
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Baloxavir Marboxil tablets (Placebo of Baloxavir Marboxil tablets) — Jiaxing AnDiCon Biotech Co.,Ltd. This is a placebo control formulation with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Baloxavir Marboxil tablets TARGET | Placebo of Baloxavir Marboxil tablets | Jiaxing AnDiCon Biotech Co.,Ltd | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Baloxavir Marboxil tablets CI watch — RSS
- Placebo of Baloxavir Marboxil tablets CI watch — Atom
- Placebo of Baloxavir Marboxil tablets CI watch — JSON
- Placebo of Baloxavir Marboxil tablets alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Baloxavir Marboxil tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-baloxavir-marboxil-tablets. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab